Overview

A Study of RC198 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours

Status:
Not yet recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
Safety study of RC198 in Subjects with Solid Tumors.
Phase:
Phase 1
Details
Lead Sponsor:
RemeGen Co., Ltd.